CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FORGETDIABETES is developing a fully automated Bionic Invisible Pancreas to revolutionize Type 1 Diabetes treatment. This device aims to provide physiological hormone delivery, reducing the need for daily insulin administration and improving patients' quality of life.
FORGETDIABETES introduces a radically new approach to Type 1 Diabetes (T1D) treatment, by developing an immuno-optimized, fully-implantable, fully-automated, Bionic Invisible Pancreas (BIP).
BIP targets physiological intraperitoneal hormone delivery, enabling an optimal glycemic control.
T1D patient number is rising, projected at 63-94 million in 2045.
T1D patients require exogenous insulin, resulting in an exorbitant number of actions: 100.000-500.000 in one patient’s life.
BIP will free T1D su…
UNIVERSITA DEGLI STUDI DI PADOVA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Pisa
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER
France, Montpellier
Type: Research institute
Activity type: Research Organisations
SME: No
Norway, Bergen
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Mainz
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
